Nasal absorption and metabolism of progesterone and 17 beta-estradiol in the rat
- PMID: 2568904
Nasal absorption and metabolism of progesterone and 17 beta-estradiol in the rat
Abstract
The utility of the nasal route for administration of progesterone and 17 beta-estradiol has been studied in rats. The results indicate that both steroids are rapidly absorbed from the nasal cavity. The bioavailability of 14C-radiolabeled progesterone administered nasally was found to be 100% of that of an iv dose. Also, the areas under the curve for the iv and nasal routes of administration were in each case directly proportional to the dose within the range studied (50-150 micrograms/rat). The bioavailability of progesterone after intraduodenal (id) administration was only 1.2% of that following an iv dose. Nasal administration of 17 beta-estradiol resulted in significantly higher blood levels than those observed following id administration. The nasal bioavailability of 17 beta-estradiol, calculated from the ratio of areas under the curve following nasal and iv administration, was 50%, 71%, and 84% for doses of 5, 10, and 20 micrograms per rat, respectively, compared with 2-5% via the id route for the same dose. The ratios of estrone to estradiol obtained after nasal administration of the different doses were lower than those obtained after id administration but higher than those obtained after iv administration, indicating that 17 beta-estradiol is oxidized to estrone in the nasal cavity and that the extent of oxidation is lower than that observed after id administration. The data also indicate that for both the iv and nasal routes of administration, estrone and estradiol constitute together 78% of the total unconjugated estrogens, whereas for the id route, these two steroids constitute 10-20% of the total unconjugated estrogens.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Nasal absorption of natural contraceptive steroids in rats-progesterone absorption.J Pharm Sci. 1981 Apr;70(4):466-7. doi: 10.1002/jps.2600700435. J Pharm Sci. 1981. PMID: 7229970
-
Uptake of estradiol or progesterone into the CSF following intranasal and intravenous delivery in rats.Eur J Pharm Biopharm. 2004 Jul;58(1):131-5. doi: 10.1016/j.ejpb.2004.02.010. Eur J Pharm Biopharm. 2004. PMID: 15207546
-
Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.Eur J Pharm Biopharm. 2008 Nov;70(3):735-40. doi: 10.1016/j.ejpb.2008.07.005. Epub 2008 Jul 18. Eur J Pharm Biopharm. 2008. PMID: 18684400
-
Nonoral routes of estrogen administration.Obstet Gynecol Clin North Am. 1987 Mar;14(1):269-98. Obstet Gynecol Clin North Am. 1987. PMID: 3306522 Review.
-
Pharmacokinetics of estrogen and progesterone in chronic kidney disease.Adv Chronic Kidney Dis. 2004 Oct;11(4):357-60. Adv Chronic Kidney Dis. 2004. PMID: 15492972 Review.
Cited by
-
The nasal mucociliary clearance: relevance to nasal drug delivery.Pharm Res. 1991 Jul;8(7):807-14. doi: 10.1023/a:1015830907632. Pharm Res. 1991. PMID: 1924131 Review.
-
Towards a generic physiologically based kinetic model to predict in vivo uterotrophic responses in rats by reverse dosimetry of in vitro estrogenicity data.Arch Toxicol. 2018 Mar;92(3):1075-1088. doi: 10.1007/s00204-017-2140-5. Epub 2017 Dec 12. Arch Toxicol. 2018. PMID: 29234833 Free PMC article.
-
Targeted brain delivery of 17 beta-estradiol via nasally administered water soluble prodrugs.AAPS PharmSciTech. 2002;3(1):E5. doi: 10.1208/pt030105. AAPS PharmSciTech. 2002. PMID: 12919005 Free PMC article.
-
Drug metabolism in the nasal mucosa.Pharm Res. 1992 Jan;9(1):1-9. doi: 10.1023/a:1018911206646. Pharm Res. 1992. PMID: 1589391 Review.
-
Absorption and distribution of estradiol from male seminal emissions during mating.J Endocrinol. 2016 Dec;231(3):245-257. doi: 10.1530/JOE-16-0247. Epub 2016 Oct 6. J Endocrinol. 2016. PMID: 27758953 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources